Liberman Alexander M. reported grant involving 4,931 shares of Medline Inc. on Nov 12, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Legal Officer
Chief Legal Officer
Filed Nov 16, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
—Shares × reported price
Shares traded
4,931Class B Common Stock
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
1,025,603Direct
Trade date
Nov 12, 2026Grant
Filed
Nov 16, 2026, 6:28 PM ET4-day reporting delay
Accession
0001104659-26-128646Code A · Transaction 402053
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 12, 2026Tax withholding413,038$26.67−$11,015,723.46Trade 402062
Nov 12, 2026Tax withholding30,815$26.82−$826,458.30Trade 402063
Nov 12, 2026Tax withholding19,027$23.04−$438,382.08Trade 402064
Nov 12, 2026Tax withholding9,518$14.35−$136,583.30Trade 402065
Nov 12, 2026Option exercise1,129,447——Trade 402054
Nov 12, 2026Option exercise85,102——Trade 402055
Nov 12, 2026Option exercise42,080——Trade 402056
Nov 12, 2026Option exercise14,449——Trade 402057
Nov 12, 2026Option exercise1,129,447——Trade 402058
Nov 12, 2026Option exercise85,102——Trade 402059
Nov 12, 2026Option exercise42,080——Trade 402060
Nov 12, 2026Option exercise14,449——Trade 402061
Nov 12, 2026Grant716,409——Trade 402050
Nov 12, 2026Grant54,287——Trade 402051
Nov 12, 2026Grant23,053——Trade 402052
16 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

MDLN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MDLN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 23, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −15%1w ago −5.7%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Reflect incentive units of Medline Holdings, LP ("Incentive Units"), which are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of common units of Medline Holdings, LP ("Common Units") generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Medline Inc.'s (the "Issuer") Class A common stock ("Class A Common Stock")) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments. F2: (Continued from Footnote 1 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC. In connection with the conversion of Incentive Units into Common Units, upon issuance of Common Units, an equivalent number of shares of Class B common stock ("Class B Common Stock") are automatically issued. F3: These Incentive Units are fully vested. F4: 60% of these Incentive Units have vested, and the remaining 40% vest in two equal annual installments beginning on April 1, 2027. F5: 40% of these Incentive Units have vested, and the remaining 60% vest in three equal annual installments beginning on March 29, 2027. F6: 20% of these Incentive Units have vested, and the remaining 80% vest in four equal annual installments beginning on March 28, 2027. F7: These securities are held by a trust, of which the Reporting Person's spouse is the trustee. F8: Pursuant to the terms of the Exchange Agreement, holders have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire. Such Common Units are held indirectly through Medline Management Aggregator LLC. F9: Shares of the Issuer's Class B Common Stock have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon the exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock are automatically cancelled. F10: Reflects Common Units deemed to be withheld in connection with the exchange of Incentive Units described herein.